Cam on CaMKII and heart failure research

At the DGK Annual Meeting 2023, Prof. Donald M. Bers, University of California, Davis, reports on his research on the pleitropic enzyme CaMKII, which is involved in various pathological processes in the body. He also talks about possible therapeutic approaches and other research topics he is working on.

Von: Romy Martínez

26.07.2023


Video interview: Heart failure research

with Prof. Donald M. Bers, University of California, Davis, School of Medicine, USA

Related Links

Prof. Mark Anderson, University of Chicago Medical Center, about his research on inhibitors of the protein kinase CaMKII and transatlantic research collaborations.

Link to the online portal of the 89th Annual Meeting

Here you will find the videos of the DGK Annual Meeting 2023.
Access is restricted to DGK members and conference attendees. You don't have a DGK membership yet? Learn more about the benefits of being a DGK member.

Das könnte Sie auch interessieren

Aficamten sicher und wirksam bei HOCM

HFA-Kongress 2024 | SEQUOIA-HCM: Neuer Myosin-Inhibitor verbessert Belastbarkeit und Lebensqualität bei hypertroph-obstruktiver Kardiomyopathie. Von Prof. B. Aßmus.

HI-Therapie: Analyse zur Umsetzung der ESC-Leitlinien

HFA-Kongress 2024 | TITRATE-HF: Wie oft werden die ESC Guidelines tatsächlich angewandt? Register-Analyse aus den Niederlanden. Von Prof. B. Aßmus.

Heart Rhythm 2024 – Highlights

HRS-Vice-President und Programm-Chair Prof. M. K. Chung fasst die diesjährigen Kongress-Highlights zusammen.

Diese Seite teilen